Understanding the adverse effects of ocriplasmin - reply.
Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts.
Michael D
MD
Tibbetts
New England Eye Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts.
Elias
E
Reichel
Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts.
Andre J
AJ
Witkin
D001766:Blindness / Q000139:chemically induced*; D004596:Electroretinography; D005260:Female; D005341:Fibrinolysin / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D010446:Peptide Fragments / Q000009:adverse effects*; D012160:Retina / Q000187:drug effects*; D012164:Retinal Diseases / Q000139:chemically induced*; D041623:Tomography, Optical Coherence
D005343:Fibrinolytic Agents; D010446:Peptide Fragments; D005341:Fibrinolysin